SCHEMBL8772644

SCHEMBL8772644

O=Cc1cccn1CC(=O)O

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.50
KMT2A Q03164 4/20 0.50
MAPT P10636 4/20 0.50
MEN1 O00255 3/20 0.50
LMNA P02545 1/20 0.50
ALOX12 P18054 1/20 0.50
RECQL P46063 1/20 0.50
ATM Q13315 1/20 0.44
TRIM24 O15164 1/20 0.44
TRIM33 Q9UPN9 1/20 0.44
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
POLB P06746 3/20 0.37
THRB P10828 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
KDM4E B2RXH2 2/20 0.37
HPGD P15428 1/20 0.37
PTGS2 P35354 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19964926 0.83 TRIM24 (0.47) ALDH1A1KMT2AMAPTMEN1LMNA
SCHEMBL29295631 0.83 ALDH1A1 (0.43) ALDH1A1KMT2AMAPTMEN1LMNA
SCHEMBL1337424 0.83 KMT2A (0.49) ALDH1A1KMT2AMAPTMEN1LMNA
SCHEMBL27001661 0.82 POLB (0.45) ALDH1A1KMT2AMAPTMEN1LMNA
SCHEMBL29954757 0.81 TRIM24 (0.46) ALDH1A1KMT2AMAPTMEN1LMNA
SCHEMBL28331384 0.81 TRIM24 (0.48) ALDH1A1KMT2AMAPTMEN1LMNA
SCHEMBL28641049 0.79 ALDH1A1 (0.43) ALDH1A1KMT2AMAPTMEN1LMNA
SCHEMBL28625554 0.79 ALDH1A1 (0.50) ALDH1A1KMT2AMAPTMEN1TRIM24
SCHEMBL11562036 0.79 TRIM24 (0.43) ALDH1A1KMT2AMAPTMEN1ATM
SCHEMBL9329560 0.79 ALDH1A1 (0.49) ALDH1A1KMT2AMAPTMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
US-9475831-B2 Formylpyrrole-based heterocycles for nucleic acid attachment to supports ILLUMINA, INC. (US) 2016-10-25 US disclosed
US-20160137677-A1 FORMYLPYRROLE-BASED HETEROCYCLES FOR NUCLEIC ACID ATTACHMENT TO SUPPORTS ILLUMINA, INC. 2016-05-19 US disclosed
US-9273074-B2 Formylpyrrole-based heterocycles for nucleic acid attachment to supports ILLUMINA, INC. (US) 2016-03-01 US disclosed
US-20150031833-A1 FORMYLPYRROLE-BASED HETEROCYCLES FOR NUCLEIC ACID ATTACHMENT TO SUPPORTS ILLUMINA, INC. 2015-01-29 US disclosed
US-8883764-B1 Formylpyrrole-based heterocycles for nucleic acid attachment to supports ILLUMINA, INC. (US) 2014-11-11 US disclosed
EP-0801083-A2 Improved functionalized resin for chemical synthesis PFIZER INC. (US) 1997-10-15 EP disclosed
US-4180660-A CONTAINING FORMYL SUBSTITUTED PYRROLE GROUP YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 1979-12-25 US disclosed
US-4122260-A CONTAINING FORMYL SUBSTITUTED PYRROLE, ANTIBIOTICS YEDA RESEARCH AND DEVELOPMENT CO., LTD. (IL) 1978-10-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150031833-A1 FORMYLPYRROLE-BASED HETEROCYCLES FOR NUCLEIC ACID ATTACHMENT TO SUPPORTS CCNY, FBL, NSUN2 ALDH1A1 1434/4885KMT2A 2474/4885MAPT 4865/4885
US-20160137677-A1 FORMYLPYRROLE-BASED HETEROCYCLES FOR NUCLEIC ACID ATTACHMENT TO SUPPORTS CCNY, FBL, NSUN2 ALDH1A1 1434/4885KMT2A 2474/4885MAPT 4865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.